Orphazyme A/S
CIK 0001764791
Revenue (TTM)
36.19M
FY Dec 2021
Net Income (TTM)
−626.54M
+1.1% YoY
FY Dec 2021
EPS Diluted (TTM)
—
FY Dec 2021
Gross Margin
—
FY Dec 2021
Operating Margin
-1,749.8%
FY Dec 2021
Net Margin
-1,731.1%
FY Dec 2021
Free Cash Flow (TTM)
—
FY Dec 2021
Cash
102.26M
FY Dec 2021
Total Debt
—
FY Dec 2021
Shares Outstanding
—
FY Dec 2021
Revenue & Net Income
Margins
Cash Flow
Revenue Growth (YoY)
No data available for this metric.